Northwestern University Feinberg School of Medicine, Department of Dermatology
Chicago, Illinois, 60611, United States
NCT Number: NCT00467233
The objective of this study is to evaluate laser treatment and acid peel for the treatment of melasma.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60611, United States
The purpose of this study is to evaluate the safety and efficacy of laser treatment and acid peel for the treatment of melasma.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Laser treatment to half of the face at each study visit
Acid peel to half of the face at each study visit
Time frame: 20 weeks
Time frame: 20 weeks
Northwestern University
Other
A Randomized, Rater-blinded, Split-face Comparison of the Efficacy of 30 % Salicylic Acid Peel vs. Q-switched Nd:Yag Laser for the Treatment of Melasma.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07727954
Hyperpigmentation, Melanosis
Tijuana, Estado de Baja California, Mexico
View Trial DetailsNCT07676994
Hyperpigmentation, Melanosis
Lahore, Pakistan
View Trial DetailsNCT07644871
Dark Spots, Hyperpigmentation
Irving, Texas, United States
View Trial DetailsNCT03877445
Hyperpigmentation, Melanosis
Nice, France
View Trial Details